MetaADEDB 2.0 @ LMMD
Hydroxyzine
(ZQDWXGKKHFNSQK-UHFFFAOYSA-N)
Structure
SMILES
OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1
Type(s)
Approved
ATC code(s)
N05BB01; N05BB51
Molecular Formula:
C21H27ClN2O2
Molecular Weight:
374.904
Log P:
2.9317
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
35.94
CAS Number(s):
68-88-2
Synonym(s)
1.
Hydroxyzine
2.
2-(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol
3.
Atarax
4.
Durrax
5.
Hydroxyzine Dihydrochloride
6.
Hydroxyzine Hydrochloride
7.
Hydroxyzine Pamoate
8.
Orgatrax
9.
Vistaril
10.
Pamoate, Hydroxyzine
External Link(s)
MeSHD006919
PubChem Compound3658
BindingDB22875
ChEBI5818
CHEMBLCHEMBL896
DrugBankDB00557
DrugCentral1400
IUPHAR/BPS Guide to PHARMACOLOGY7199
KEGGcpd:C07045
dr:D08054
Therapeutic Target DatabaseD0O6SX
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Suicide attemptFAERS: 30US FAERS
2Drug ineffectiveFAERS: 26OFFSIDES
US FAERS
3Drug exposure during pregnancyFAERS: 19US FAERS
4OverdoseFAERS: 19OFFSIDES
US FAERS
5AnxietyFAERS: 17OFFSIDES
US FAERS
6PruritusFAERS: 15
Canada Vigilance: 3
11034010CTD
Canada Vigilance
US FAERS
7Injection site necrosisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
8HeadacheFAERS: 13
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
9SomnolenceFAERS: 13
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
10FatigueFAERS: 12OFFSIDES
US FAERS
11Feeling abnormalFAERS: 10OFFSIDES
US FAERS
12Medication ErrorFAERS: 10US FAERS
13AgitationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
14Incorrect route of drug administrationFAERS: 8US FAERS
15Injection site painFAERS: 8US FAERS
16NauseaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
17TremorFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
18UrticariaFAERS: 8
Canada Vigilance: 4
1683191
2569996
17632232
CTD
SIDER
Canada Vigilance
US FAERS
19DizzinessFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
20HypersomniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
21VomitingFAERS: 7US FAERS
22AmnesiaFAERS: 6OFFSIDES
US FAERS
23Completed SuicideFAERS: 6US FAERS
24HypersensitivityFAERS: 6
Canada Vigilance: 1
2570798CTD
SIDER
Canada Vigilance
US FAERS
25Product substitution issueFAERS: 6US FAERS
26SepsisFAERS: 6US FAERS
27Skin necrosisFAERS: 6US FAERS
28Abdominal PainFAERS: 5OFFSIDES
US FAERS
29AngioedemaFAERS: 5US FAERS
30Depressed Level of ConsciousnessFAERS: 5SIDER
US FAERS
31Drug ineffective for unapproved indicationFAERS: 5US FAERS
32MalaiseFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
33MalnutritionFAERS: 5US FAERS
34Respiratory DepressionFAERS: 5US FAERS
35SwellingFAERS: 5US FAERS
36Urinary RetentionFAERS: 5US FAERS
37Bipolar DisorderFAERS: 4OFFSIDES
US FAERS
38Drug screen positiveFAERS: 4US FAERS
39Limb discomfortFAERS: 4US FAERS
40Lip swellingFAERS: 4US FAERS
41Mental status changesFAERS: 4US FAERS
42ParotitisFAERS: 4US FAERS
43Product use in unapproved indicationFAERS: 4US FAERS
44PsoriasisFAERS: 4OFFSIDES
US FAERS
45SyncopeFAERS: 4
Canada Vigilance: 1
19057127CTD
Canada Vigilance
US FAERS
46TachycardiaFAERS: 45690527CTD
US FAERS
47Abdominal InfectionFAERS: 3US FAERS
48Altered state of consciousnessFAERS: 3US FAERS
49Anaphylactic shockFAERS: 3US FAERS
50AngerFAERS: 3OFFSIDES
US FAERS
51CellulitisFAERS: 3OFFSIDES
US FAERS
52DeliriumFAERS: 3US FAERS
53Drug administration errorFAERS: 3US FAERS
54Drug prescribing errorFAERS: 3US FAERS
55Drug withdrawal syndromeFAERS: 3US FAERS
56ErythemaFAERS: 3
Canada Vigilance: 4
Canada Vigilance
US FAERS
57FibromyalgiaFAERS: 3OFFSIDES
US FAERS
58FlatulenceFAERS: 3US FAERS
59General physical health deteriorationFAERS: 3OFFSIDES
US FAERS
60Hepatorenal SyndromeFAERS: 3US FAERS
61InflammationFAERS: 3US FAERS
62LethargyFAERS: 3US FAERS
63Middle insomniaFAERS: 3OFFSIDES
US FAERS
64NecrosisFAERS: 3US FAERS
65Neonatal disorderFAERS: 3US FAERS
66Oropharyngeal painFAERS: 3OFFSIDES
US FAERS
67PainFAERS: 3
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
68PallorFAERS: 3OFFSIDES
US FAERS
69PalpitationsFAERS: 3US FAERS
70PoisoningFAERS: 3US FAERS
71Product use issueFAERS: 3US FAERS
72ScreamingFAERS: 3US FAERS
73ShockFAERS: 3US FAERS
74Status EpilepticusFAERS: 3US FAERS
75Abdominal discomfortFAERS: 2US FAERS
76AlopeciaFAERS: 2OFFSIDES
US FAERS
77Anaphylactoid ReactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
78ArthralgiaFAERS: 2US FAERS
79AstheniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
80Atrial FibrillationFAERS: 2US FAERS
81Back PainFAERS: 2US FAERS
82Blood potassium increasedFAERS: 2US FAERS
83BronchospasmFAERS: 2US FAERS
84Cerebral vasoconstrictionFAERS: 2US FAERS
85Chemical submissionFAERS: 2US FAERS
86Chest PainFAERS: 2OFFSIDES
US FAERS
87Chest discomfortFAERS: 2US FAERS
88ChromaturiaFAERS: 2US FAERS
89ConstipationFAERS: 2US FAERS
90Contraindicated product administeredFAERS: 2US FAERS
91Coronary Artery DiseaseFAERS: 2US FAERS
92DementiaFAERS: 2US FAERS
93Disseminated Intravascular CoagulationFAERS: 2OFFSIDES
US FAERS
94Drug DependenceFAERS: 2US FAERS
95Drug effect incompleteFAERS: 2US FAERS
96Drug exposure via breast milkFAERS: 2US FAERS
97Drug screen false positiveFAERS: 2US FAERS
98Drug toxicityFAERS: 2OFFSIDES
US FAERS
99DysphoniaFAERS: 2US FAERS
100EosinophiliaFAERS: 2US FAERS
101Fat necrosisFAERS: 2US FAERS
102FormicationFAERS: 2OFFSIDES
US FAERS
103Gastric FistulaFAERS: 2US FAERS
104Histiocytosis haematophagicFAERS: 2US FAERS
105Hormone level abnormalFAERS: 2OFFSIDES
US FAERS
106HyperparathyroidismFAERS: 2US FAERS
107Injection Site ReactionFAERS: 2US FAERS
108Injection site ulcerFAERS: 2US FAERS
109Meconium plug syndromeFAERS: 2US FAERS
110Medication residueFAERS: 2US FAERS
111Memory impairmentFAERS: 2US FAERS
112Mental impairmentFAERS: 2OFFSIDES
US FAERS
113Muscle necrosisFAERS: 2OFFSIDES
US FAERS
114MyositisFAERS: 2US FAERS
115No adverse eventFAERS: 2US FAERS
116OliguriaFAERS: 2US FAERS
117ParanoiaFAERS: 2US FAERS
118PneumoniaFAERS: 2US FAERS
119Poor quality sleepFAERS: 2US FAERS
120Product quality issueFAERS: 2US FAERS
121Radial nerve palsyFAERS: 2US FAERS
122Respiratory distressFAERS: 2US FAERS
123Restless Legs SyndromeFAERS: 2US FAERS
124RestlessnessFAERS: 2US FAERS
125Self-induced vomitingFAERS: 2US FAERS
126Septic ShockFAERS: 2US FAERS
127Skin UlcerFAERS: 2US FAERS
128SoporFAERS: 2US FAERS
129StressFAERS: 2OFFSIDES
US FAERS
130Toxicity to various agentsFAERS: 2US FAERS
131Transaminases increasedFAERS: 2OFFSIDES
US FAERS
132Unresponsive to stimuliFAERS: 2US FAERS
133Vein painFAERS: 2US FAERS
134Visual ImpairmentFAERS: 2US FAERS
135Weight decreasedFAERS: 2US FAERS
136Accidental drug intake by childFAERS: 1US FAERS
137Accidental exposure to product by childFAERS: 1US FAERS
138Accidental overdoseFAERS: 1US FAERS
139Alanine Aminotransferase IncreasedFAERS: 1US FAERS
140Ammonia increasedFAERS: 1US FAERS
141Angle Closure GlaucomaFAERS: 1US FAERS
142Anticholinergic SyndromeFAERS: 1US FAERS
143ApathyFAERS: 1OFFSIDES
US FAERS
144AphasiaFAERS: 1US FAERS
145Application site necrosisFAERS: 1US FAERS
146ArteriosclerosisFAERS: 1OFFSIDES
US FAERS
147ArthritisFAERS: 1OFFSIDES
US FAERS
148ArthropathyFAERS: 1OFFSIDES
US FAERS
149Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
150AsthmaFAERS: 1US FAERS
151BedriddenFAERS: 1OFFSIDES
US FAERS
152BicytopeniaFAERS: 1US FAERS
153BlepharospasmFAERS: 1US FAERS
154Blood PressureFAERS: 1US FAERS
155Blood creatine phosphokinase abnormalFAERS: 1US FAERS
156Blood glucose decreasedFAERS: 1OFFSIDES
US FAERS
157Blood glucose increasedFAERS: 1US FAERS
158Bronchial ObstructionFAERS: 1OFFSIDES
US FAERS
159Burning sensationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
160CataractFAERS: 1OFFSIDES
US FAERS
161CatatoniaFAERS: 115782600CTD
US FAERS
162Cerebrovascular accidentFAERS: 1US FAERS
163Chemical burn of skinFAERS: 1US FAERS
164ChillsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
165Choking sensationFAERS: 1OFFSIDES
US FAERS
166ChokingFAERS: 1OFFSIDES
US FAERS
167Circumstance or information capable of leading to medication errorFAERS: 1OFFSIDES
US FAERS
168ClonusFAERS: 1US FAERS
169ClumsinessFAERS: 1US FAERS
170Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
171Congenital heart valve disorderFAERS: 1US FAERS
172Congenital renal disorderFAERS: 1US FAERS
173Contraindicated product prescribedFAERS: 1US FAERS
174CryingFAERS: 1US FAERS
175CyanosisFAERS: 1US FAERS
176DeafnessFAERS: 1US FAERS
177DehydrationFAERS: 1OFFSIDES
US FAERS
178DiscomfortFAERS: 1US FAERS
179Disease ProgressionFAERS: 1US FAERS
180DisorientationFAERS: 1US FAERS
181Drug administered at inappropriate siteFAERS: 1US FAERS
182Drug effect delayedFAERS: 1US FAERS
183Drug effective for unapproved indicationFAERS: 1US FAERS
184Drug level increasedFAERS: 1US FAERS
185Drug resistanceFAERS: 1US FAERS
186Dry skinFAERS: 1OFFSIDES
US FAERS
187DysgeusiaFAERS: 1US FAERS
188DysuriaFAERS: 1US FAERS
189Electrocardiogram abnormalFAERS: 1US FAERS
190EpilepsyFAERS: 1US FAERS
191EructationFAERS: 1US FAERS
192Erythema MultiformeFAERS: 1US FAERS
193EscharFAERS: 1US FAERS
194ExcoriationFAERS: 1OFFSIDES
US FAERS
195Expired product administeredFAERS: 1US FAERS
196ExtravasationFAERS: 1US FAERS
197Eye irritationFAERS: 1US FAERS
198False positive investigation resultFAERS: 1US FAERS
199Feeding disorder neonatalFAERS: 1US FAERS
200Foreign body aspirationFAERS: 1US FAERS
201Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
202Gastrointestinal PainFAERS: 1US FAERS
203GlaucomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
204Gluten sensitivityFAERS: 1US FAERS
205Growth retardationFAERS: 1US FAERS
206HomicideFAERS: 1US FAERS
207HungerFAERS: 1US FAERS
208Incorrect dose administeredFAERS: 1US FAERS
209Injection site extravasationFAERS: 1US FAERS
210Injection site thrombosisFAERS: 1US FAERS
211Intentional drug misuseFAERS: 1US FAERS
212Intentional misuseFAERS: 1US FAERS
213Intentional product misuseFAERS: 1US FAERS
214Intentional self-injuryFAERS: 1OFFSIDES
US FAERS
215Intercepted drug dispensing errorFAERS: 1US FAERS
216Joint injuryFAERS: 1US FAERS
217Joint swellingFAERS: 1US FAERS
218LeukopeniaFAERS: 1US FAERS
219Mastication disorderFAERS: 1US FAERS
220Metabolic acidosisFAERS: 1US FAERS
221MyalgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
222MydriasisFAERS: 1US FAERS
223Myocardial InfarctionFAERS: 1US FAERS
224Neck PainFAERS: 1US FAERS
225Neonatal oversedationFAERS: 1US FAERS
226Nerve injuryFAERS: 1US FAERS
227NervousnessFAERS: 1US FAERS
228NeutropeniaFAERS: 1US FAERS
229Neutrophilic dermatosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
230NoduleFAERS: 1US FAERS
231Obesity surgeryFAERS: 1US FAERS
232Ocular HypertensionFAERS: 1US FAERS
233Oral mucosal eruptionFAERS: 1US FAERS
234OsteitisFAERS: 1US FAERS
235Painful ejaculationFAERS: 1US FAERS
236Pancreatic enlargementFAERS: 1US FAERS
237Panic DisorderFAERS: 1US FAERS
238PapuleFAERS: 1US FAERS
239Peripheral swellingFAERS: 1US FAERS
240Personality ChangeFAERS: 1US FAERS
241Pharmaceutical product complaintFAERS: 1US FAERS
242PhlebitisFAERS: 15690527CTD
US FAERS
243Poor sucking reflexFAERS: 1US FAERS
244PriapismFAERS: 17969858CTD
US FAERS
245Product barcode issueFAERS: 1US FAERS
246Product physical issueFAERS: 1US FAERS
247Prostatic AdenomaFAERS: 1US FAERS
248PseudoparalysisFAERS: 1US FAERS
249PurpuraFAERS: 1US FAERS
250Rash erythematousFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
251Renal tubular disorderFAERS: 1US FAERS
252Respiratory FailureFAERS: 1US FAERS
253Reversible cerebral vasoconstriction syndromeFAERS: 1US FAERS
254Sinus TachycardiaFAERS: 1US FAERS
255Sinus bradycardiaFAERS: 1US FAERS
256Skin ErosionFAERS: 1US FAERS
257Skin IndurationFAERS: 1OFFSIDES
US FAERS
258Skin lacerationFAERS: 1US FAERS
259Skin lesionFAERS: 1OFFSIDES
US FAERS
260Skin reactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
261Skin test positiveFAERS: 1US FAERS
262Soft tissue necrosisFAERS: 1US FAERS
263SomnambulismFAERS: 1US FAERS
264StillbirthFAERS: 1US FAERS
265Subcorneal pustular dermatosisFAERS: 1US FAERS
266Suspected counterfeit productFAERS: 1US FAERS
267Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
268Tardive DyskinesiaFAERS: 1OFFSIDES
US FAERS
269Therapy non-responderFAERS: 1US FAERS
270ThrombocytopeniaFAERS: 1US FAERS
271ThrombophlebitisFAERS: 1US FAERS
272ThrombosisFAERS: 1US FAERS
273Transaminases abnormalFAERS: 1US FAERS
274Urinary IncontinenceFAERS: 1US FAERS
275Urinary tract infectionFAERS: 1US FAERS
276Urine alcohol test positiveFAERS: 1US FAERS
277Urine output increasedFAERS: 1US FAERS
278VasculitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
279Ventricular FibrillationFAERS: 1US FAERS
280Violence-related symptomFAERS: 1US FAERS
281Viral myocarditisFAERS: 1US FAERS
282Visual disturbanceFAERS: 1OFFSIDES
US FAERS
283Vitreous floatersFAERS: 1US FAERS
284Wound infection staphylococcalFAERS: 1US FAERS
285Wrong technique in product usage processFAERS: 1US FAERS
286nervous system disorderFAERS: 1US FAERS
287Abdominal symptomOFFSIDES
288Abnormal visionOFFSIDES
289Acid refluxOFFSIDES
290ActinomycosisOFFSIDES
291Activities of daily living impairedOFFSIDES
292Acute respiratory failureOFFSIDES
293Acute sinusitisOFFSIDES
294AdenomaOFFSIDES
295Adverse eventOFFSIDES
296AgoraphobiaOFFSIDES
297AgraphiaOFFSIDES
298Albumin globulin ratio abnormalOFFSIDES
299Allergy to arthropod stingOFFSIDES
300AlveolitisOFFSIDES
301AnhedoniaOFFSIDES
302AnorexiaOFFSIDES
303AnosmiaOFFSIDES
304Anti-erythropoietin antibodyOFFSIDES
305Anxiety Disorders7781586CTD
306Application site erosionOFFSIDES
307Application site painOFFSIDES
308Application site rashOFFSIDES
309Application site vesiclesOFFSIDES
310AsbestosisOFFSIDES
311AscitesOFFSIDES
312Aspiration PneumoniaOFFSIDES
313AtaxiaCanada Vigilance: 1Canada Vigilance
314AtelectasisOFFSIDES
315Atrial tachycardiaOFFSIDES
316AuraOFFSIDES
317Bacterial test positiveOFFSIDES
318BalanitisOFFSIDES
319Basal cell carcinomaOFFSIDES
320Bed restOFFSIDES
321Bile Duct StenosisOFFSIDES
322Biliary dilatationOFFSIDES
323Blood GlucoseOFFSIDES
324Blood alkaline phosphatase increasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
325Blood amylase increasedOFFSIDES
326Blood chloride decreasedOFFSIDES
327Blood cholesterolOFFSIDES
328Blood count abnormalOFFSIDES
329Blood creatine increasedOFFSIDES
330Blood creatinine decreasedOFFSIDES
331Blood creatinine increasedOFFSIDES
332Blood fibrinogenOFFSIDES
333Blood homocysteineOFFSIDES
334Blood potassium decreasedOFFSIDES
335Blood sodium increasedOFFSIDES
336Blood sodiumOFFSIDES
337Blood triglycerides increasedOFFSIDES
338Blurred visionOFFSIDES
339Bone scan abnormalOFFSIDES
340BradycardiaCanada Vigilance: 1Canada Vigilance
OFFSIDES
341Brain DeathOFFSIDES
342Brain natriuretic peptide increasedOFFSIDES
343BronchitisOFFSIDES
344BruxismCanada Vigilance: 1Canada Vigilance
345CalciphylaxisOFFSIDES
346Cardiac DeathOFFSIDES
347Cardiac function test abnormalOFFSIDES
348Carotid artery occlusionOFFSIDES
349Catheter site painOFFSIDES
350Cerebral artery stenosisOFFSIDES
351CholecystitisOFFSIDES
352Chorea20108362CTD
353Choroidal DetachmentOFFSIDES
354Chronic Obstructive Airway DiseaseOFFSIDES
355CirrhosisOFFSIDES
356Coagulation time shortenedOFFSIDES
357Cold sweatOFFSIDES
358Compression fractureOFFSIDES
359Concomitant disease progressionOFFSIDES
360ConfabulationOFFSIDES
361Congenital tricuspid valve incompetenceOFFSIDES
362Contact DermatitisOFFSIDES
363Coronary angioplastyOFFSIDES
364CraniotomyOFFSIDES
365Cubital Tunnel SyndromeOFFSIDES
366Culture positiveOFFSIDES
367Cutaneous CandidiasisOFFSIDES
368Cytolytic hepatitisOFFSIDES
369DebridementOFFSIDES
370DemyelinationOFFSIDES
371Dental prosthesis placementOFFSIDES
372DermatitisCanada Vigilance: 1Canada Vigilance
SIDER
373Device leakageOFFSIDES
374DiabetesOFFSIDES
375Diabetes mellitus inadequate controlOFFSIDES
376Diabetic NephropathyOFFSIDES
377Diabetic RetinopathyOFFSIDES
378DiarrheaOFFSIDES
379Diastolic dysfunctionOFFSIDES
380DiplopiaOFFSIDES
381Disorders of Excessive Somnolence2148177CTD
382DiverticulitisOFFSIDES
383DrowsinessOFFSIDES
SIDER
384Drug abuserOFFSIDES
385Drug withdrawal headacheOFFSIDES
386Ductus arteriosus premature closureOFFSIDES
387Dysthymic DisorderOFFSIDES
388DystoniaOFFSIDES
389EctropionOFFSIDES
390EczemaCanada Vigilance: 1Canada Vigilance
OFFSIDES
391Ejection Fraction DecreasedOFFSIDES
392Electrocardiogram ST segment abnormalOFFSIDES
393EmbolismOFFSIDES
394Emotional disorderOFFSIDES
395Emotional distressOFFSIDES
396Endodontic procedureOFFSIDES
397Enterocolitis bacterialOFFSIDES
398EnuresisOFFSIDES
399Escherichia infectionOFFSIDES
400Escherichia urinary tract infectionOFFSIDES
401Esophageal StenosisOFFSIDES
402Euphoric moodOFFSIDES
403Exfoliative rashOFFSIDES
404Fatty LiverOFFSIDES
405Feeling ColdOFFSIDES
406Fixed drug eruptionSIDER
407FrustrationOFFSIDES
408Gallop rhythm presentOFFSIDES
409Gastric pH decreasedOFFSIDES
410GastrinomaOFFSIDES
411GastroenteritisOFFSIDES
412Gastrointestinal hypomotilityOFFSIDES
413GranulocytosisOFFSIDES
414Grip strengthOFFSIDES
415HaemoconcentrationOFFSIDES
416Hepatic vein occlusionOFFSIDES
417Hepatomegaly28108177CTD
418HyperkeratosisOFFSIDES
419HyperpigmentationOFFSIDES
420HyperreflexiaOFFSIDES
421HyperventilationOFFSIDES
422HypoparathyroidismOFFSIDES
423HypotensionCanada Vigilance: 25690527CTD
SIDER
Canada Vigilance
424HypoxiaOFFSIDES
425Immunosuppressant drug levelOFFSIDES
426IncontinenceOFFSIDES
427Increased upper airway secretionOFFSIDES
428InfectionOFFSIDES
429Injection site inflammationCanada Vigilance: 1Canada Vigilance
430Insulin-requiring type 2 diabetes mellitusOFFSIDES
431IntertrigoOFFSIDES
432Intervertebral disc disorderOFFSIDES
433Jugular vein distensionOFFSIDES
434Keratitis siccaOFFSIDES
435Kidney FailureOFFSIDES
436Left Ventricular HypertrophyOFFSIDES
437LeukoencephalopathyOFFSIDES
438Leukopenia neonatalOFFSIDES
439Long QT Syndrome19057127CTD
440Malignant neoplasm progressionOFFSIDES
441MetrorrhagiaCanada Vigilance: 1Canada Vigilance
442Mitral Valve StenosisOFFSIDES
443Muscle WeaknessOFFSIDES
444Muscle strainOFFSIDES
445Muscle tightnessOFFSIDES
446Musculoskeletal chest painOFFSIDES
447MyelocytosisOFFSIDES
448MyelodysplasiaOFFSIDES
449MyoglobinaemiaOFFSIDES
450MyopiaOFFSIDES
451NasopharyngitisOFFSIDES
452Nephrogenic Fibrosing DermopathyOFFSIDES
453NephrolithiasisOFFSIDES
454Nervous tensionOFFSIDES
455Neuroblastoma recurrentOFFSIDES
456NeurodermatitisOFFSIDES
457Neuroleptic Malignant SyndromeOFFSIDES
458Neutropenic colitisOFFSIDES
459Neutrophil count decreasedOFFSIDES
460NocturiaOFFSIDES
461Non-cardiac chest painOFFSIDES
462Ocular icterusOFFSIDES
463Oculomucocutaneous syndromeOFFSIDES
464Open reduction of fractureOFFSIDES
465Open woundOFFSIDES
466Oral dischargeOFFSIDES
467Oral mucosal hypertrophyOFFSIDES
468OsteomyelitisOFFSIDES
469OsteopeniaOFFSIDES
470OsteoporosisOFFSIDES
471PCO2 decreasedOFFSIDES
472Pancreatic Duct StenosisOFFSIDES
473Parent-child problemOFFSIDES
474Patellofemoral Pain SyndromeOFFSIDES
475PeriarthritisOFFSIDES
476Pericardial effusionOFFSIDES
477PertussisOFFSIDES
478PharyngitisCanada Vigilance: 1Canada Vigilance
479PhonophobiaOFFSIDES
480PhotodermatosisOFFSIDES
481PolyhydramniosOFFSIDES
482Polysubstance dependenceOFFSIDES
483PolyuriaOFFSIDES
484PoriomaniaOFFSIDES
485Prolapse repairOFFSIDES
486Protein total decreasedOFFSIDES
487Pulmonary HypertensionOFFSIDES
488Pulmonary arterial hypertensionOFFSIDES
489Pulmonary congestionOFFSIDES
490Pyoderma GangrenosumOFFSIDES
491Radiation skin injuryOFFSIDES
492Rectal ProlapseOFFSIDES
493Renal cystOFFSIDES
494Renal tubular necrosisOFFSIDES
495RhabdomyolysisOFFSIDES
496Rhinitis19672097CTD
497RhinorrheaOFFSIDES
498Seizures16199350CTD
499Shunt malfunctionOFFSIDES
500SinusitisOFFSIDES
501Skin WrinklingOFFSIDES
502Skin neoplasm excisionOFFSIDES
503Skin tightnessOFFSIDES
504Sleep TalkingOFFSIDES
505SmokerOFFSIDES
506Sphincter of Oddi DysfunctionOFFSIDES
507Spinal claudicationOFFSIDES
508Staphylococcal Scalded Skin SyndromeOFFSIDES
509Stasis dermatitisOFFSIDES
510StuporSIDER
511SubileusOFFSIDES
512Substance Withdrawal Syndrome16199350CTD
513Superinfection lungOFFSIDES
514TendinitisOFFSIDES
515Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
516Therapy cessationOFFSIDES
517Therapy regimen changedOFFSIDES
518Throat cancerOFFSIDES
519Tinea PedisOFFSIDES
520TinnitusCanada Vigilance: 1Canada Vigilance
521Tobacco userOFFSIDES
522Tobacco withdrawal symptomsOFFSIDES
523Tongue movement disturbanceCanada Vigilance: 1Canada Vigilance
524Tooth ExtractionOFFSIDES
525ToothacheCanada Vigilance: 1Canada Vigilance
526Torsades de Pointes19057127CTD
527Troponin TOFFSIDES
528UlcerOFFSIDES
529Umbilical herniaOFFSIDES
530Urine amphetamine positiveOFFSIDES
531Venous InsufficiencyOFFSIDES
532Ventricular hypokinesiaOFFSIDES
533Victim of homicideOFFSIDES
534Viral pharyngitisOFFSIDES
535Vitamin A DeficiencyOFFSIDES
536Vitreous DetachmentOFFSIDES
537Vulvovaginal burning sensationOFFSIDES
538Weight GainOFFSIDES
539XerosisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.